12/31/10 - 262,215 - ($17.51) Year-end 2010 close
12/31/11 - 481,195 - ($21.64) Year-end 2011 close
12/31/12 - 701,950 - ($25.08) Year-end 2012 close
01/03 - 737,125 - ($25.85) RSI 61.8, low 2013 valuation to date
01/10 - 761,540 - ($26.76) RSI 73.0
01/17 - 764,155 - ($26.83) RSI 69.1
01/18 - 762,945 - ($26.54) RSI 61.8
01/25 - 771,965 - ($27.00) RSI 68.0
01/29 - 776,115 - ($27.70) RSI 73.4, high 2013 stock close to date
01/30 - 772,670 - ($27.51) RSI 73.9, ex-dividend 24 cents, sold 70% of Pfizer holdings
01/31 - 772,120 - ($27.28) RSI 68.2
02/01 - 773,220 - ($27.63) RSI 71.8, Zoetis IPO
Up 10.2%. 2013 Portfolio gain to date
Up 11.1%. 2013 Pfizer stock price gain to date including one 24-cent dividend
Up 06.1%. S & P 500 gain to date (1,426 to 1,513)
Sentiment: Hold